Rational Pharmacotherapy in Cardiology

Advanced search


Full Text:


Methods that allow to systematize the accumulated information on specifically formulated questions, analyze it and make reliable findings are of great interest and popularity with the emergence of a huge number of studies and publications in various fields of medicine, a significant increase in information, failure to identify weak effects in the individual studies. The use of systematic reviews and high-quality meta-analysis is an analytical basis of evidence-based medicine, it is a very valuable tool for decision-making at the level of practitioner, health care leaders and experts in the preparation of guidelines and legislation concerning the use of the most effective and safe treatments, when planning future research, in the development of rational health policy. Features of methods of systematic review and meta-analysis and their strengths and weaknesses are discussed in the article. The authors present the historical facts of occurrence of the Cochrane Collaboration, whose main task is to systematize and analyze accumulated information from a variety of medical research. The contribution of Russian researchers into this field of medical science is also assessed.

About the Authors

Yu. V. Lukina
State Research Center for Preventive Medicine, Moscow
Russian Federation

S. Yu. Martsevich
State Research Center for Preventive Medicine, Moscow
Russian Federation

N. P. Kutishenko
State Research Center for Preventive Medicine, Moscow
Russian Federation


1. Spiegel AS. Evidence-based medicine. Prospects for homotoxicology. Monograph. Moscow: Arnebia; 2004. In Russian (Шпигель А.С. Доказательная медицина. Перспективы для гомотоксикологии. Монография. Москва: Арнебия; 2004).

2. Greenhalgh T. How to Read a Paper: The Basics of Evidence-Based Medicine, 4th Edition. West Sussex, UK: Wiley-Blackwell; 2010.

3. Feigin VL. Fundamentals of the meta-analysis: theory and practice. International Journal of Medical Practice 1999; 7: 7-13. In Russian (Фейгин В.Л. Основы мета-анализа: теория и практика. Международный Журнал Медицинской Практики 1999; 7: 7-13).

4. Plavinsky SL meta-analysis Guide: a tutorial. St. Petersburg: SPbMAPO; 2001. In Russian (Плавинский С.Л. Руководство по мета-анализу: учебное пособие. СПб: СПбМАПО, 2001).

5. Oganov RG, ed. Basics of evidence-based medicine. Educational handbook. Moscow: Silitseya-Polygraph; 2010. In Russian (Оганов Р.Г., ред. Основы доказательной медицины. Учебно-методическое пособие. Москва: Силицея-Полиграф; 2010.

6. Lau J, Antman EM, Jimenez-Silva J et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992, 327(4): 248-54.

7. Bangalore S., Makani H., Radford M. Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials. Am J Med 2014;127(10): 939-53.

8. Whitehead A. Meta-analysis in controlled clinical trials. West Sussex, UK: Wiley-Blackwell; 2002.

9. Rebrova OY. Statistical analysis of medical data. The application package STATISTICA applications. Moscow: MediaSfera; 2006. In Russian (Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. Москва: МедиаСфера; 2006).

10. Nakaoka H., Inoue I. Meta-analysis of genetic association studies: methodologies, between-study heterogeneity and winner’s curse. J Hum Genet 2009; 54: 615-23.

11. Chalmers I., Sackett D., Silagy C. The Cochrane Collaboration. In: Maynard A., Chalmers I., eds. Nonrandom reflections on health services research: on 25 anniversary of Archie Cochrane's Effectiveness and Efficiency. London: BMJ Books; 1997: 231-49.

12. Eysenck HJ. Meta-analysis and its problems. BMJ 1994, 309(6957): 789-92.

13. Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Open Med 2009; 3(3): 123-30.

14. Moher D, Cook D.J., Eastwood S. et al. for the QUOROM Group. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 1999; 354: 1896-900.

15. Verbitskaya EV A meta-analysis the problem of the inclusion of Russian publications. Available at: Checked by 09.04.2016. In Russian (Вербицкая Е.В. Метаанализ – проблема включения российских публикаций. Доступно на: Проверено 09.04.2016).

16. Beloborodov SM. A systematic review and meta-analysis. Problemy reproduktsii 2003; 4: 7-11. In Russian (Белобородов С.М. Систематический обзор и мета-анализ. Проблемы Репродукции 2003, 4: 7-11).

17. Bokeria LA, Bokeria OL, Glushko LA. Meta-analysis of modern clinical studies and long-term results of cardiac resynchronization therapy. Annaly Aritmologii 2012; 1: 44-55. In Russian (Бокерия Л.А., Бокерия О.Л., Глушко Л.А. Мета-анализ современных клинических исследований и отдаленные результаты применения ресинхронизирующей терапии. Анналы Аритмологии 2012; 1: 44-55).

18. Petrov VI, Shatalova OV, Gorbatenko VS, et al. The efficacy and safety of new oral anticoagulants in patients with venous thromboembolic complications. A meta-analysis. Rational Pharmacotherapy in Cardiology 2016; 12 (1): 31-9. In Russian (Петров В.И., Шаталова О.В., Горбатенко В.С. и др. Эффективность и безопасность новых пероральных антикоагулянтов у больных венозными тромбоэмболическими осложнениями: мета-анализ. Рациональная Фармакотерапия в Кардиологии 2016; 12(1): 31-9).

19. Fox BD, Kahn SR, Langleben D, et al. Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials. BMJ 2012; 345: e7498.

20. Hulle T., Kooiman J., Den Exter P.L. et al. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis 2013; 12: 320-8.

21. Kakkos S.K., Kirkilesis G.I., Tsolakis I.A. Editor’s Choice Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials. European Journal of Vascular and Endovascular Surgery 2014; 48(5): 565-75.

22. Küsters L.a, Snel A., Kruip M.J.H.A. The efficacy and safety of non-vitamin K oral anticoagulants in the treatment of acute venous thromboembolism. Erasmus Journal of Medicine 2015; 5(1): 34-8.

23. Cohen AT, Hamilton M., Mitchell SA et al. Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis. PLoS One. 2015 Dec 30;10(12):e0144856.

24. Hokusai VTE Investigators, Buller HR, Decousus H, Grosso MA, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. The New England Journal of Medicine 2013; 369(15):1406-15.

25. Sagitov RT, Glaser MG. The use of indapamide controlled release in patients with arterial hypertension: a meta-analysis and comparison of the results of the Russian and foreign public research. Problemy Zhenskogo Zdorov'ya 2009; 4 (4): 5-15. In Russian (Сайгитов Р.Т., Глезер М.Г. Применение индапамида с контролируемым высвобождением у больных артериальной гипертензией: метаанализ и сопоставление результатов российский и зарубежных открытых исследований. Проблемы Женского Здоровья 2009; 4(4): 5-15).

26. Gao D, Ning N, Niu X, et al. Trimetazidine: a meta-analysis of randomised controlled trials in heart failure. Heart 2011;97:278-86.

27. Zhang L, Lu Y, Jiang H, et al. Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis. J Am Coll Cardiol 2012;59:913-22.

28. Chrusciel P., Rysz J., Banach M. Defining the Role of Trimetazidine in the Treatment of Cardiovascular Disorders: Some Insights on Its Role in Heart Failure and Peripheral Artery Disease. Drugs 2014; 74(9): 971-80.

29. Verbitskaya EV, Melnikova EV, Ivanova GE. Meta-analysis of the literature: transient ischemic attack before the stroke the clinical equivalent of ischemic preconditioning. Vestnik Vosstanovitel'noy Meditsiny 2014; 1: 44-9. In Russian (Вербицкая Е.В., Мельникова Е.В., Иванова Г.Е. Мета-анализ литературы: транзиторная ишемическая атака перед инсультом – клинический эквивалент ишемического прекондиционирования. Вестник Восстановительной Медицины 2014, 1: 44-9).

30. Doroshenko AS, Kropotkina EA, Morozova KV, Fokin VA. Post-marketing monitoring data meta-analysis application Jodantipyrin for emergency prevention of tick-borne encephalitis endemic on Russian territory. Terra medica. Infektsionnye zabolevaniya 2013; 1: 27-9. In Russian (Дорошенко А.С., Кропоткина Е.А., Морозова К.В., Фокин В.А. Мета-анализ данных пострегистрационного мониторинга применения йодантипирина для экстренной профилактики клещевого энцефалита на эндемичных территориях России. Terra medica. Инфекционные заболевания 2013; 1: 27-9).

31. Ziganshina LE, Abakumova TR. Cerebrolysin in the treatment of acute ischemic stroke. Vestnik RAMN. Aktual'nye Voprosy Nevrologii i Psikhiatrii 2013; 1: 21-9. In Russian (Зиганшина Л.Е., Абакумова Т.Р. Церебролизин в лечении острого ишемического инсульта. Вестник РАМН. Актуальные Вопросы Неврологии и Психиатрии 2013; 1: 21-9).


For citations:

Lukina Yu.V., Martsevich S.Yu., Kutishenko N.P. SYSTEMATIC REVIEW AND META-ANALYSIS: PITFALLS OF METHODS. Rational Pharmacotherapy in Cardiology. 2016;12(2):180-185. (In Russ.)

Views: 1158

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)